Innocoll AG (INNL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Innocoll AG (INNL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010930
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innocoll AG (Innocoll), formerly Innocoll Holdings Inc is a specialty pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product portfolio includes xaracoll, cogenzia and collaguard; and approved products include collatampg, regenepro, zorpreva, collacare suite, durieva, and septocoll. It has partnership with other pharma companies to market its various products. It operates across the US, Ireland, and Germany. Innocoll is headquartered in Athlone, Ireland.

Innocoll AG (INNL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innocoll AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Innocoll AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Innocoll AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Innocoll AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Innocoll AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Innocoll AG, Medical Equipment, Deal Details 10
Venture Financing 10
Innocoll Raises US$1.5 Million In Venture Financing 10
Innocoll Raises US$2 Million In Venture Financing 11
Innocoll Raises US$2 Million In Venture Financing 12
Innocoll Raises US$1.1 Million In Venture Financing 13
Innocoll Secures US$3.3 Million In Financing 14
Private Equity 15
Gurnet Point Acquires Innocoll for USD209 Million 15
Partnerships 17
Innocoll Enters Into Licensing Agreement With Biomet 3i For CollaCare Dental Products 17
Merus Labs International Enters Into Licensing Agreement With Innocoll For CollaGUARD 18
Innocoll Enters Into Distribution Agreement With Pioneer Pharma 19
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 20
Equity Offering 21
Innocoll Raises USD40 Million in Public Offering of Shares 21
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 23
Innocoll Raises USD58.5 Million in IPO 24
Innocoll AG – Key Competitors 26
Innocoll AG – Key Employees 27
Innocoll AG – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Mar 16, 2017: Innocoll Holdings Announces Fourth Quarter and Full-Year 2016 Financial and Operating Results and Provides Corporate Update 29
Aug 17, 2016: Innocoll Holdings Announces Second Quarter 2016 Financial and Operating Results and Provides Corporate Update 31
May 31, 2016: Innocoll Holdings Announces First Quarter 2016 Financial and Operating Results and Provides Corporate Update 34
Mar 17, 2016: Innocoll Holdings Announces Fourth Quarter and Full-Year 2015 Financial and Operating Results and Provides Corporate Update 37
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Innocoll AG, Medical Equipment, Key Facts, 2016 2
Innocoll AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Innocoll AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Innocoll AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Innocoll AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Innocoll AG, Deals By Market, 2011 to YTD 2017 8
Innocoll AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Innocoll Raises US$1.5 Million In Venture Financing 10
Innocoll Raises US$2 Million In Venture Financing 11
Innocoll Raises US$2 Million In Venture Financing 12
Innocoll Raises US$1.1 Million In Venture Financing 13
Innocoll Secures US$3.3 Million In Financing 14
Gurnet Point Acquires Innocoll for USD209 Million 15
Innocoll Enters Into Licensing Agreement With Biomet 3i For CollaCare Dental Products 17
Merus Labs International Enters Into Licensing Agreement With Innocoll For CollaGUARD 18
Innocoll Enters Into Distribution Agreement With Pioneer Pharma 19
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 20
Innocoll Raises USD40 Million in Public Offering of Shares 21
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 23
Innocoll Raises USD58.5 Million in IPO 24
Innocoll AG, Key Competitors 26
Innocoll AG, Key Employees 27
Innocoll AG, Subsidiaries 28

★海外企業調査レポート[Innocoll AG (INNL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otsuka Pharmaceutical Co., Ltd.:企業のM&A・事業提携・投資動向
    Otsuka Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Otsuka Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • New York Life Insurance Company:企業のM&A・事業提携・投資動向
    New York Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New York Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務分析
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sumitomo Electric Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • TransForce Inc.:企業のM&A・事業提携・投資動向
    TransForce Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TransForce Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • ReCor Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary ReCor Medical Inc (ReCor Medical), a subsidiary of Otsuka Holdings Co Ltd, is a medical device company that designs and manufactures a proprietary ultrasound ablation system for performing renal denervation. The company develops paradise renal denervation system, a therapeutic non-focused ul …
  • Arsanis Inc (ASNS):製薬・医療:M&Aディール及び事業提携情報
    Summary Arsanis Inc (Arsanis) is a clinical-stage biopharmaceutical company that focuses on the development of monoclonal antibody immunotherapies for the treatment of critical infectious diseases. The company’s pipeline product portfolio includes ASN100, for staphylococcus aureus; ASN500, targets r …
  • Euroclear Plc:企業の戦略・SWOT・財務分析
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kumagai Gumi Co Ltd (1861):企業の財務・戦略的SWOT分析
    Kumagai Gumi Co Ltd (1861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • American Municipal Power Inc:企業の戦略的SWOT分析
    American Municipal Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Movenpick Schweiz AG:企業の戦略・SWOT・財務情報
    Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report Summary Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • EnCana Corp (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • Ponti’s Group Limited:企業の戦略・SWOT・財務情報
    Ponti's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Ponti's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Topy Industries Ltd:企業の戦略・SWOT・財務分析
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Macquarie Group Ltd:企業の戦略・SWOT・財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cullinan Holdings Limited
    Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Brunswick Corporation (BC):企業の財務・戦略的SWOT分析
    Brunswick Corporation (BC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆